We conducted CCK‐8 and Transwell assays to assess the effects of the G3BP1 K76R mutation on the cisplatin sensitivity, as well as the migratory and invasive capabilities of NPC cells. Here, G3BP1 is linked to nasopharyngeal carcinoma.